“You are very ignorant of mAbs, Covid19, and good journalism if you can write an entire story on an under-touted treatment type and not even mention Leronlimab (PRO140) made by Cytodyn. I mean, it’s only the furthest along mAb with both clinical and statistical efficacy, with a 10+ year proven safety record in over 1000 people. It’s also already applied for EUA in both the U.S. and the U.K. given that is is much further along than the treatments you highlight. I know this is not a comprehensive list, but for goodness sakes, if it’s a paid advertisement not looking for truth or value, please state as much and save me the heart ache. It’s ignorance of this sort that makes it hard for small companies a la Cytodyn to help people, save lives, and help restart our economy. Hope your weekend dive into this research wasn’t too onerous.”